Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Outcome of Relapsed DLBCL Patients, Treated with Polatuzumab-BR or Polatuzumab-R: Real Life Data

Yafit Segman, MD, Elena Ribakovsky, MD, Abraham Avigdor, MD, Vladimir Vainstein, MD, Neta Goldschmidt, MD, Shimrit Ringelstein Harlev, MD, Odit Gutwein, Uri Abadi, MD, Anatoly Nemets, MD, Orit Sofer, Najib Dally, MD, Kalman Filanovsky, MD, Merav Leiba, MD, Nadav Sarid, MD, Noam Benyamini, MD, Yair Herishanu, MD, Ron Ram, MD, Chava Perry, MD PhD, Irit Avivi

Blood (2019) 134 (Supplement_1): 5321.

https://doi.org/10.1182/blood-2019-124164

Published: 2019

Journal Articles

Real-Life Data on the Outcome of Daratumomab-Refractory Myeloma Patients: Multi-Center Experience

Noam Benyamini, MD, Adir S, MD, Moshe E. Gatt, MD, Yael C Cohen, MD, Irit Avivi, MD, Svetlana Trestman, MD, Olga Shvetz, MD, Tamar Tadmor, MD, Najib Dally, MD, Yevgeny Chober, Hila Magen, MD, Chezi Ganzel, MD, Osnat Jarchowcky Dolberg, Celia Suriu, MD, Noa Lavi, MD

Blood (2018) 132 (Supplement 1): 3259.

https://doi.org/10.1182/blood-2018-99-115985

Published: 2018

Journal Articles

Characteristics and Outcome of Multiple Myeloma Patients Presenting with Anemia Only: a Retrospective Multi-Center Study

Tamir Shragai, MD, Moshe E. Gatt, MD, Adir Shaulov, MD, Eirini Katodritou, MD, Theodora Triantafyllou, MD, Noa Lavi, MD, Anastasia Pouli, MD PhD, Anastasia Sioni, Iuliana Vaxman, MD BA, Miri Zektser, MD, Chezi Ganzel, MD, Noam Benyamini, MD, Svetlana Trestman, MD, Tomer ziv Baran, PhD, Yael C Cohen, MD, Irit Avivi, MD

Blood (2018) 132 (Supplement 1): 5578.

https://doi.org/10.1182/blood-2018-99-116372

Published: 2018

Journal Articles

Monoallelic Deletion of the Whole Locus of Immunoglobulin Heavy Chain Gene [Del(IGH)] Is Associated with a Better Prognosis in Newly Diagnosed Multiple Myeloma

Luba Trakhtenbrot, PhD, Adrian Duek, MD, Ninette Amariglio, PhD, Abraham Avigdor, MD, Noam Benyamini, MD, Izhar Hardan, MD, Itay Zilbershatz, MD, Chezi Ganzel, MD, Olga Shvetz, MD, Ronit Leiba, PhD, Marina Izak, MD, Cohen Ziv, Ba, Gabriela Rozic, PhD, Arnon Nagler, MD, Merav Leiba

Blood (2017) 130 (Supplement 1): 5368.

https://doi.org/10.1182/blood.V130.Suppl_1.5368.5368

Published: 2017

Journal Articles

Bortezomib-Activated Macrophages Contribute to Multiple Myeloma Progression Via Cancer Stem Cell Enrichment

Ofrat Beyar Katz, MD, Ksenia Magidey Klein, M.Sc, Michael Timaner, PhD, Ziv Raviv, PhD, Noam Benyamini, MD, Benjamin Brenner, MD, Yuval Shaked, PhD

Blood (2017) 130 (Supplement 1): 2269.

https://doi.org/10.1182/blood.V130.Suppl_1.2269.2269

Published: 2017

Journal Articles

The Effect of Lenalidomide on Multiple Myeloma Associated Macrophages

Noam Benyamini, MD, Samah Waked, BS.c., Lina Bisharat, MSc, Noam Bettman, PhD, Tami Katz, PhD

Blood (2016) 128 (22): 3689.

https://doi.org/10.1182/blood.V128.22.3689.3689

Published: 2016

Journal Articles

Patient-Reported Quality of Life before and after Stopping Treatment in the ENESTop Trial of Treatment-Free Remission for Patients with Chronic Myeloid Leukemia in Chronic Phase

Blood (2016) 128 (22): 1891.

https://doi.org/10.1182/blood.V128.22.1891.1891

Published: 2016

Journal Articles

Treatment-Free Remission in Patients with Chronic Myeloid Leukemia in Chronic Phase According to Reasons for Switching from Imatinib to Nilotinib: Subgroup Analysis from ENESTop

Timothy P. Hughes, MD FRACP, FRCPA, MBBS, FAAHMS, Carla Maria Boquimpani, Naoto Takahashi, MD PhD, Noam Benyamini, MD, Nelma Cristina D Clementino, MD, Vasily Shuvaev, MD, Sikander Ailawadhi, MD, Jeffrey H. Lipton, MD PhD, Anna G Turkina, Prof., MD, Elena Beatriz Moiraghi, MD, Franck E. Nicolini, MD PhD, Jolanta Dengler, Tomasz Sacha, Dong-Wook Kim, MD PhD, Rafik Fellague-Chebra, MD MSc, Sandip Acharya, MSc, Nancy Krunic, PhD, Yu Jin, MS, François-Xavier Mahon, MD PhD

Blood (2016) 128 (22): 792.

https://doi.org/10.1182/blood.V128.22.792.792

Published: 2016

Journal Articles

Intermediate Dose Methotrexate Improves Overall Survival and Progression-Free Survival of Patients with Diffuse Large B Cell Lymphoma Treated with the R-CHOP or CHOP Regimen

Eldad J Dann, MD, Vered Heffes, BsC, Tatiana Mashiach, MSc, Noam Benyamini, MD, Irit Avivi, MD, Netanel A Horowitz, MD

Blood (2015) 126 (23): 2698.

https://doi.org/10.1182/blood.V126.23.2698.2698

Published: 2015

Journal Articles

T he Effect of A dherence-Encouraging Interventions on Adherence to Tyrosine K inas e I nhibitor T reatment in Chronic Myeloid Leukemia ( TAKE-IT ): A Pre-Post Intervention Pilot Study

Avi Leader, MD, Noam Benyamini, MD, Sabina De Geest, PhDRN, Juliet Dreyer, RN MA, Bronya Calvarysky, MSc Clin Pharm, Sara Gechler, PhD, Alina Amitai, PharmD, Osnat Jarchowsky-Dolberg, MD, Giora Sharf, Eric Tousset, M.Sc., Opher Caspi, MDPhD, Martin Ellis, MD, Itai Levi, MD, Anat Gafter-Gvili, MD, Pia Raanani, MD

Blood (2015) 126 (23): 4034.

https://doi.org/10.1182/blood.V126.23.4034.4034

Published: 2015

Journal Articles

Risk of Progression and Survival in Newly Diagnosed Multiple Myeloma Patients Non-Responsive to Bortezomib-Based Induction Therapy: an Observational Multicenter International Study

Yael C Cohen, MD, Erel Joffe, MDMSc, Noam Benyamini, MD, Meletios A. Dimopoulos, MD, Svetlana Trestman, MD, Viki Held, PhD, Irit Avivi, MD, Efstathios Kastritis, MD

Blood (2014) 124 (21): 3488.

https://doi.org/10.1182/blood.V124.21.3488.3488

Published: 2014

Journal Articles

Elevated Involved Light Chains Discordant to the Increase of the Involved Heavy Chains Identifies a Subset of Multiple Myeloma Patients with Worse Outcome

Erel Joffe, MDMSc, Yael C Cohen, MD, Irit Avivi, MD, Noam Benyamini, MD, Svetlana Trestman, MD, Viki Held, PhD, Meletios A. Dimopoulos, MD, Efstathios Kastritis, MD

Blood (2014) 124 (21): 2132.

https://doi.org/10.1182/blood.V124.21.2132.2132

Published: 2014

Journal Articles

Immature Platelet Fraction Predicts Outcome and Sepsis Development in Critically Ill Patients Admitted to a General Intensive Care Unit, but Not in Neutropenic Patients

Doaa Okasha, MD, Galit Sarig, PhD, Noam Benyamini, MD, Ronit Tamir, PhD, Ofrat Beyar Katz, MD, Lena Markuze, MSc, Marielle Kaplan, PhD, Yishai Ofran, MD

Blood (2014) 124 (21): 2164.

https://doi.org/10.1182/blood.V124.21.2164.2164

Published: 2014

Journal Articles

Acute Myeloid Leukemia Diagnosed During Pregnancy: Facing Challenges. Systematic Review and Analysis Of 174 Reported Cases

Israel Henig, MD, Liat Vidal, MD MSc, Oryan Henig, MD, Noam Benyamini, MD, Irit Avivi, MD

Blood (2013) 122 (21): 1421.

https://doi.org/10.1182/blood.V122.21.1421.1421

Published: 2013

Journal Articles

Preemptive Detection Of JC Virus In Peripheral Blood Of Patients Undergoing Allogeneic Stem Cell Transplantation: A Potential Tool To Prevent Progressive Multifocal Leukoencephalopathy In High-Risk Patients?

Irit Avivi, MD, Talya Wittmann, BSc, Noam Benyamini, MD, Zipora Kra-Oz, PhD, Moran Szwarcwort, Ilana Oren, MD, Jacob M. Rowe, MD, Tsila Zuckerman, MD, Netanel Horowitz, MD

Blood (2013) 122 (21): 4537.

https://doi.org/10.1182/blood.V122.21.4537.4537

Published: 2013

Journal Articles

Early Bone Marrow Examination, On The Fifth Day Of Induction For AML, Is Highly Predictive Of Response

Blood (2013) 122 (21): 3893.

https://doi.org/10.1182/blood.V122.21.3893.3893

Published: 2013

Journal Articles

Integration Of CT-Based Measurements Into PET Assessment Significantly Improves The Positive Predictive Value Of Surveillance FDG PET/CT In Patients With Diffuse Large B Cell Lymphoma

Noa Lavi, MD, Gali Shapira, MD, Ariel Zilberlicht, MD, Noam Benyamini, MD, Dan Farbstein, MD, Eldad J Dann, MD, Rachel Bar-Shalom, MD, Irit Avivi, MD

Blood (2013) 122 (21): 4296.

https://doi.org/10.1182/blood.V122.21.4296.4296

Published: 2013

Journal Articles

High-Dose Cyclophosphamide In Combination With G-CSF Versus G-CSF Alone For Mobilization Of Hematopoietic Stem Cells After Induction Therapy Including Velcade, Cyclophosphamide and Dexacort

Noam Benyamini, MD, Irit Avivi, MD, Eldad J Dann, MD, Tsila Zuckerman, MD, Lavi Noa, MD, Tami Katz, Ph.D

Blood (2013) 122 (21): 5369.

https://doi.org/10.1182/blood.V122.21.5369.5369

Published: 2013

Journal Articles

Absolute Monocyte Count At Diagnosis Is a Poor Prognostic Factor and Impacts Survival in Diffuse Large B-Cell Lymphoma: A Collaborative Multi-Center Study Involving 1026 Patients.

Tamar Tadmor, MD, Bari Alessia, MD, Stefano Sacchi, Luigi Marcheselli, Eliana Valentina Liardo, Irit Avivi, MD, Noam Benyamini, MD, Dina Attias, MD, Samantha Pozzi, MD, Massimo Federico, MD, Aaron Polliack, MD

Blood (2012) 120 (21): 2651.

https://doi.org/10.1182/blood.V120.21.2651.2651

Published: 2012

Journal Articles

Reactivation of JC Virus in 171 Allografted Patients: Incidence and Clinical Significance

Irit Avivi, MD, Talia Wittman, Noam Benyamini, MD, Zipora Kra-Oz, PhD, Moran Szwrcwort, PhD, Ilana Oren, MD, Jacob M Rowe, MD, Israel Henig, MD, Tsila Zuckerman, MD, Netanel Horowitz, MD

Blood (2012) 120 (21): 4148.

https://doi.org/10.1182/blood.V120.21.4148.4148

Published: 2012

NARROW

Outcome of Relapsed DLBCL Patients, Treated with Polatuzumab-BR or Polatuzumab-R: Real Life Data

Real-Life Data on the Outcome of Daratumomab-Refractory Myeloma Patients: Multi-Center Experience

Characteristics and Outcome of Multiple Myeloma Patients Presenting with Anemia Only: a Retrospective Multi-Center Study

Monoallelic Deletion of the Whole Locus of Immunoglobulin Heavy Chain Gene [Del(IGH)] Is Associated with a Better Prognosis in Newly Diagnosed Multiple Myeloma

Bortezomib-Activated Macrophages Contribute to Multiple Myeloma Progression Via Cancer Stem Cell Enrichment

The Effect of Lenalidomide on Multiple Myeloma Associated Macrophages

Patient-Reported Quality of Life before and after Stopping Treatment in the ENESTop Trial of Treatment-Free Remission for Patients with Chronic Myeloid Leukemia in Chronic Phase

Treatment-Free Remission in Patients with Chronic Myeloid Leukemia in Chronic Phase According to Reasons for Switching from Imatinib to Nilotinib: Subgroup Analysis from ENESTop

Intermediate Dose Methotrexate Improves Overall Survival and Progression-Free Survival of Patients with Diffuse Large B Cell Lymphoma Treated with the R-CHOP or CHOP Regimen

T he Effect of A dherence-Encouraging Interventions on Adherence to Tyrosine K inas e I nhibitor T reatment in Chronic Myeloid Leukemia ( TAKE-IT ): A Pre-Post Intervention Pilot Study

Risk of Progression and Survival in Newly Diagnosed Multiple Myeloma Patients Non-Responsive to Bortezomib-Based Induction Therapy: an Observational Multicenter International Study

Elevated Involved Light Chains Discordant to the Increase of the Involved Heavy Chains Identifies a Subset of Multiple Myeloma Patients with Worse Outcome

Immature Platelet Fraction Predicts Outcome and Sepsis Development in Critically Ill Patients Admitted to a General Intensive Care Unit, but Not in Neutropenic Patients

Acute Myeloid Leukemia Diagnosed During Pregnancy: Facing Challenges. Systematic Review and Analysis Of 174 Reported Cases

Preemptive Detection Of JC Virus In Peripheral Blood Of Patients Undergoing Allogeneic Stem Cell Transplantation: A Potential Tool To Prevent Progressive Multifocal Leukoencephalopathy In High-Risk Patients?

Early Bone Marrow Examination, On The Fifth Day Of Induction For AML, Is Highly Predictive Of Response

Integration Of CT-Based Measurements Into PET Assessment Significantly Improves The Positive Predictive Value Of Surveillance FDG PET/CT In Patients With Diffuse Large B Cell Lymphoma

High-Dose Cyclophosphamide In Combination With G-CSF Versus G-CSF Alone For Mobilization Of Hematopoietic Stem Cells After Induction Therapy Including Velcade, Cyclophosphamide and Dexacort

Absolute Monocyte Count At Diagnosis Is a Poor Prognostic Factor and Impacts Survival in Diffuse Large B-Cell Lymphoma: A Collaborative Multi-Center Study Involving 1026 Patients.

Reactivation of JC Virus in 171 Allografted Patients: Incidence and Clinical Significance

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only